| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (B Stem KO) / (B Stem WT) | Abundance Ratio (log2): (B Stem KO) / (B Stem WT) | Abundance Ratio P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Adj. P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Variability [%]: (B Stem KO) / (B Stem WT) | Abundances (Grouped): B Stem KO | Abundances (Grouped): B Stem WT | Abundances (Grouped) CV [%]: B Stem KO | Abundances (Grouped) CV [%]: B Stem WT | Abundances (Scaled): F2: 129, Sample, B Stem KO, 1 | Abundances (Scaled): F2: 130, Sample, B Stem KO, 2 | Abundances (Scaled): F2: 131, Sample, B Stem KO, 3 | Abundances (Scaled): F2: 126, Sample, B Stem WT, 1 | Abundances (Scaled): F2: 127, Sample, B Stem WT, 2 | Abundances (Scaled): F2: 128, Sample, B Stem WT, 3 | Abundances (Normalized): F2: 129, Sample, B Stem KO, 1 | Abundances (Normalized): F2: 130, Sample, B Stem KO, 2 | Abundances (Normalized): F2: 131, Sample, B Stem KO, 3 | Abundances (Normalized): F2: 126, Sample, B Stem WT, 1 | Abundances (Normalized): F2: 127, Sample, B Stem WT, 2 | Abundances (Normalized): F2: 128, Sample, B Stem WT, 3 | Abundance: F2: 129, Sample, B Stem KO, 1 | Abundance: F2: 130, Sample, B Stem KO, 2 | Abundance: F2: 131, Sample, B Stem KO, 3 | Abundance: F2: 126, Sample, B Stem WT, 1 | Abundance: F2: 127, Sample, B Stem WT, 2 | Abundance: F2: 128, Sample, B Stem WT, 3 | Abundances Count: F2: 129, Sample, B Stem KO, 1 | Abundances Count: F2: 130, Sample, B Stem KO, 2 | Abundances Count: F2: 131, Sample, B Stem KO, 3 | Abundances Count: F2: 126, Sample, B Stem WT, 1 | Abundances Count: F2: 127, Sample, B Stem WT, 2 | Abundances Count: F2: 128, Sample, B Stem WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | Q9DAS9 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 OS=Mus musculus OX=10090 GN=Gng12 PE=1 SV=3 | 0 | 58.274 | 71 | 6 | 28 | 6 | 72 | 8 | 8.97 | 1.025 | 0.04 | 0.939963227 | 0.999366244 | 10.07 | 102.6 | 97.4 | 5.1 | 11.5 | 104.4 | 100.4 | 94.3 | 95.4 | 113.5 | 92 | 2179.6 | 2096.8 | 1968.9 | 1991.5 | 2368.8 | 1921.2 | 1907.3 | 1994.9 | 1968.9 | 1759.8 | 2213.4 | 1854.6 | 8 | 8 | 8 | 8 | 8 | 8 | regulation of biological process;response to stimulus | membrane | protein binding;signal transducer activity | Pf00631 | 14701 | Gng12 | 6 | "Glucagon signaling in metabolic regulation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Adrenaline,noradrenaline inhibits insulin secretion; Activation of G protein gated Potassium channels; Vasopressin regulates renal water homeostasis via Aquaporins; Glucagon-type ligand receptors; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits" | ENSMUSG00000036402.13 | Morphine addiction; Cholinergic synapse; Retrograde endocannabinoid signaling; Regulation of actin cytoskeleton; MAPK signaling pathway; Dopaminergic synapse; Ras signaling pathway; GABAergic synapse; Chemokine signaling pathway; Glutamatergic synapse; Pathways in cancer; Alcoholism; PI3K-Akt signaling pathway; Circadian entrainment; Serotonergic synapse | Chemokine signaling pathway; G Protein Signaling Pathways; Focal Adhesion-PI3K-Akt-mTOR-signaling pathway; Myometrial Relaxation and Contraction Pathways; Regulation of Actin Cytoskeleton; Calcium Regulation in the Cardiac Cell | 0 |